ABOUT this BLOG and How to use it

WELCOME to Stu's Views & MS News. A product of MS Views and News, a Not-for-Profit [501c3] organization. Founded in 2008, we provide educational Multiple Sclerosis information via live seminars and via the internet.

Key-Notes: Our live seminars average approx 60 people per educational program. Our blog is visited over 2900 times per week and our website is visited by thousands each month.

Register at our website to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in (90) Countries.

On this blog see our Directory, Archives, recent Blog Posts & so much more. Use the Blog Search box (enter a keyword). See our Facebook information AND Links to other MS Organizations & bloggers. Scroll through entire page, to find information that could EMPOWER You. At the Bottom of this page, see informational videos and some for fun.

Disclaimer: "Stu's Views & MS News" / 'MS Views and News' does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Like this blog? - CLICK "LIKE"

Wednesday, May 26, 2010

“10 Years & Counting” Celebrates a Decade of National Team COPAXONE® Achievements Teva Pharmaceuticals


Teva Neuroscience today announced the tenth anniversary of Team COPAXONE® (glatiramer acetate injection), a group of 10 inspirational individuals who have challenged their multiple sclerosis (MS) diagnosis to pursue the active lives they love through a commitment to healthy living. In its 10 years, the Team’s members have ranged from triathlete to snowmobiler, from racecar driver to LPGA caddy, but all have shared a common conviction to live their lives to the fullest despite an MS diagnosis while promoting the benefits of healthy diet, exercise and drug therapy adherence,though individual results may vary.




In celebration of this decade of achievement, Teva Neuroscience is looking for an eleventh extraordinary member to join the Team. To be considered, a person must share the Team’s common goal of refusing to let MS stand in the way of their dreams and be actively engaging in a sport or pursuit they love. Submissions will be screened for eligibility, and top entries will be posted to the Team’s Web site for public voting. The newest member of Team COPAXONE® will be announced in late 2010 and will receive sponsorship support to participate in their chosen activity.




Those wishing to be considered to join Team COPAXONE® should visit www.TeamCopaxone.com by September 1, 2010.


“When I was first diagnosed, I feared losing the ability to ride my horses,” said competitive barrel horse racer Laura Kimball, “but it’s a different fear for everyone who receives this kind of news. Being a part of Team COPAXONE® for nearly two years has given me the opportunity to sharewith others the success that I’ve found by maintaining a daily commitment to my health. We’re so excited to welcome a new member to our efforts – there are so many people with amazing stories to share.”
Highlights from the Team’s upcoming year include:
  • Mountain climber Wendy Booker’s attempt at summiting Mt. Everest, a feat that will make her the first person with a public diagnosis of MS to have climbed the seven tallest mountains on each continent
  • Para-equestrian Mary Jordan’s try at the 2010 World Equestrian Games’ U.S. team
  • Mountain biker Grace Ragland’s appearance in “Race Across the Sky,” a film chronicling a 100 mile cross-country race in Leadville, Co. Grace completed in 2009




Read more: http://www.pharmiweb.com/PressReleases/pressrel.asp?ROW_ID=22701#ixzz0p3gahhn6



0 comments: